In 2024, major IPOs are announced: Fortegra Group offers 18 million shares, Reddit eyes a $5 billion valuation, and NYSE President is optimistic about the IPO landscape. Holcim plans to list its North American business, Tokyo Metro prepares for a public listing, Cerebras Systems considers a 2024 IPO, Zelis weighs sale or IPO over $15 billion, and Renault cancels Ampere's IPO due to market conditions.

Anta Sports is investing heavily in Amer Sports' IPO, while Hedgeye is skeptical of Amer's valuation, Klarna Bank AB plans a U.S. IPO, Kallyope Inc. targets an IPO for obesity drugs, GTMS eyes a Hong Kong IPO, Swiggy prepares for a $1 billion IPO, CG Oncology and ArriVent BioPharma increase their IPO share offerings.

Air Astana plans a London IPO in February, aiming to raise $120 million. South Korea's Kbank resumes IPO plans, expecting a valuation around $3.73 billion. Mexican grocery chain BBB Foods files for a U.S. IPO. CG Oncology increases its IPO size to $201 million for Nasdaq listing.

VettaFi highlights the IPOX®-based First Trust US Equity Opportunities ETF (FPX) as a way for investors to gain access to the latest newly listed companies.

Reddit, Shein, Deutsche Entertainment AG, Pertamina International Shipping, Kyverna Therapeutics, Alto Neuroscience, NeOnc Technologies, Kaspi.kz, and Xiaocaiyuan International Holding are all planning IPOs in 2024. Reddit aims for a March IPO, while Shein's US IPO faces a cybersecurity probe in China. Deutsche Entertainment AG seeks a Frankfurt relisting, Pertamina aims for fleet expansion, Kyverna focuses on biotech, Alto targets CNS disorder treatments, NeOnc upsizes its IPO for brain cancer therapies, Kaspi.kz shareholders plan a US IPO, and Xiaocaiyuan files for a Hong Kong IPO.

In 2024, global IPO activity is expected to surge, with Nasdaq and London markets showing signs of revival, while Saudi Arabia, the Asia Pacific region, and Greece announce significant IPOs. Tech and startup sectors are particularly buoyant, with notable listings in the Middle East, India leading Asia's IPO charge, and Greece planning a major airport IPO.

Several companies across various sectors are making strategic moves towards Initial Public Offerings (IPOs) globally. Shein faces U.S. IPO delays due to Chinese regulations, while Air Astana targets an IPO for expansion. LianLian DigiTech re-applies for a Hong Kong IPO, Airwallex prepares for an IPO within two years, Lion Air considers a Jakarta IPO to raise funds, and Hellman & Friedman explores selling or listing Enverus.

In 2024, the IPO market is showing signs of recovery, with German retailer Douglas planning a Frankfurt listing valued at €7 billion, and Australia expecting a market rebound. The biotech sector is optimistic, with Metagenomi and CG Oncology announcing IPOs, signaling renewed investor interest and a potential market rally.

In 2024, the global IPO landscape is flourishing with major filings across various sectors. Amer Sports aims for a $10 billion US IPO, while Germany anticipates a surge in listings. Telix Pharmaceuticals eyes a Nasdaq IPO, Sodexo prepares to spin off Pluxee, and BrightSpring Health seeks a $1 billion IPO. Dubai establishes Parkin for its IPO, Smith Douglas Homes plans a real estate IPO, South Korea's market is vibrant with nine upcoming IPOs, and the biotech sector sees a surge in M&A and IPOs, forecasting a bright 2024.

Saudi Arabian airline Flynas plans a 2024 IPO with Goldman Sachs and Morgan Stanley's assistance, as part of Saudi Arabia's economic diversification efforts. This follows the successful IPO of SAL Saudi Logistics Services. Additionally, the Lebara telecommunications group is considering an IPO amid customer growth. Europe's ESMA is working to boost the region's IPO appeal. ServiceTitan is preparing for a 2024 IPO, and Schott Pharma's stock rose post-SDAX inclusion. Fractyl Health files for a $100 million IPO for diabetes and obesity treatments.